Early exposure, Canadian approach: GMR only! [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2009-02-08 01:44 (5975 d 07:26 ago) – Posting: # 3205
Views: 23,039

Dear D. Labes,

❝ ❝ Sometimes I forget the true country of the brave and the free - Canada...


❝ Brave and free already since a long time ago regarding their outstanding handling of Cmax :ok:.


Not to see the wood for the trees!

Though I quoted Eric correctly (the sentence is already given in Health Canada's Notice for Industry for rapid onset drugs from June 2005) I overlooked that nobody asks for a confidence interval. :-D
So only the mean should lie within 0.8-1.25.

Going back to my examples:
first post
Example 1: nonparametric tmax BE, parametric AUCReftmax BE
Example 2: nonparametric tmax not BE, parametric AUCReftmax not BE
second post
Example 3: nonparametric tmax not BE, parametric AUCReftmax BE (though close: GMR 81.2%)

I guess the 'Canadian way' would be an alternative for EMEA's 'statistical experts' not accepting dreadful nonparametrics - and dealing with high variability whilst not loosing their faces.
Hopefully somebody suggested it to EMEA; I realized it just today (one week too late) and suggested in my comments keeping the nonparametric method. :rotfl:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
35 visitors (0 registered, 35 guests [including 9 identified bots]).
Forum time: 10:10 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5